143 related articles for article (PubMed ID: 24046180)
41. [Erythrophagocytosis by blast cells and de novo T cell LAL without cytogenetic abnormalities in a Moroccan patient].
Kahouli S; Zahid H; Khorassani ME; Kabbaj SE; Benkirane M; Messaoudi N
Pan Afr Med J; 2020; 36():202. PubMed ID: 32963668
[TBL] [Abstract][Full Text] [Related]
42. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
43. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
44. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
Chen VM; McIlroy K; Loui JP; Fay K; Ward C
Pathology; 2003 Aug; 35(4):325-9. PubMed ID: 12959763
[TBL] [Abstract][Full Text] [Related]
45. 8p11 associated myeloid/lymphoid neoplasms: An illustrative case report of this rare entity and review of literature.
Jabbar N; Mansoor N; Taimoor M; Jawed O; Ashraf MS
J Pak Med Assoc; 2020 Apr; 70(4):743-746. PubMed ID: 32296228
[TBL] [Abstract][Full Text] [Related]
46. [Immunophenotypes on blast cells of chronic myelogenous leukemia].
Motoji T
Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336
[TBL] [Abstract][Full Text] [Related]
47. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
48. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
Dorfman DM; Morgan EA; Pelton A; Unitt C
Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327
[TBL] [Abstract][Full Text] [Related]
49. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
50. Acute myelocytic leukemia and human immunodeficiency virus infection.
Olalla J; Costa JR; Rubio R; Jiménez E; Toscano R; Pulido F
Am J Med; 2001 Jul; 111(1):79. PubMed ID: 11460853
[No Abstract] [Full Text] [Related]
51. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M
Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901
[TBL] [Abstract][Full Text] [Related]
52. Romboutsia-induced bone marrow necrosis at presentation of acute myeloid leukaemia.
Seviar D; Nyunt K; Sayer C; Wright D; Rider T
Br J Haematol; 2022 Jan; 196(2):262. PubMed ID: 34581439
[No Abstract] [Full Text] [Related]
53. Case Study Interpretation--Houston: Case 3. Early T-cell precursor-acute lymphoblastic leukemia.
Park S
Cytometry B Clin Cytom; 2011; 80(4):261-3. PubMed ID: 21638770
[No Abstract] [Full Text] [Related]
54. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
55. [Reversed C.P.C.: Aggressive NK-cell leukemia/lymphoma].
Koyama T
Rinsho Byori; 2001 Mar; Suppl 115():140-3. PubMed ID: 11391932
[TBL] [Abstract][Full Text] [Related]
56. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
Natkunam Y; Cherry AM; Cornbleet PJ
Arch Pathol Lab Med; 2001 Mar; 125(3):413-8. PubMed ID: 11231495
[TBL] [Abstract][Full Text] [Related]
57. Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma.
DiGiuseppe JA; Wood BL
Cytometry B Clin Cytom; 2019 Jul; 96(4):256-265. PubMed ID: 31231940
[TBL] [Abstract][Full Text] [Related]
58. [Myeloid/natural killer cell precursor acute leukemia diagnosed by cell marker analysis].
Miura R; Yoshimi M; Kikuchi Y; Takahashi T
Rinsho Ketsueki; 2013 Jun; 54(6):579-83. PubMed ID: 23823098
[TBL] [Abstract][Full Text] [Related]
59. Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia.
Milosevic I
Turk J Haematol; 2016 Dec; 33(4):353-354. PubMed ID: 27751969
[No Abstract] [Full Text] [Related]
60. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]